TriSalus Life Sciences, Inc.TLSINASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending higher, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-41.19M
↓ 37% below average
Average (4y)
$-30.02M
Historical baseline
Range
High:$-677600.00
Low:$-51.17M
CAGR
+179.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-41.19M | +19.5% |
| 2023 | $-51.17M | -54.6% |
| 2022 | $-33.10M | -38.2% |
| 2021 | $-23.95M | -3435.3% |
| 2020 | $-677600.00 | - |